The Executive Board and Supervisory Board work hand in hand for CO.DON’s ongoing development. Meet our team.


The Executive Board of CO.DON AG is responsible for managing the company. It acts independently and is responsible for the company meeting the objectives laid down in its articles of association. To this end it takes the necessary entrepreneurial measures, i.e. decisions on staffing, finances and strategy.

A team of division managers assists the Executive Board with the development and implementation of the company strategy. They form the Executive Committee.

Tilmann Bur

Executive Board

Tilmann Bur, born in 1964, has been a board member of CO.DON AG since June 2019. 

He is an internationally experienced sales and marketing manager. With over 20 years’ experience he worked in professional relationship management with decision-makers in orthopedic and surgical clinics in particular, as well as in setting up and managing national and international sales organizations and distribution networks.

After completing his education and subsequently working in various hospitals as a manager for the operating theatre, Tilmann joined Haemonetics in 1999, where he initially worked as a product specialist for complex products in the field of blood management for orthopaedics and cardio surgery. After gaining additional business management qualifications, he held various national and international positions, for example, as Head of Sales and Authorised Representative for Haemonetics Germany, as Marketing Director at Haemonetics Europe and Managing Director at Haemonetics Austria. After working for Biosafe as Director Global Sales and Marketing, as well as a member of the leadership team, Tilmann joined R-Biopharm as Director Global Sales for the division of food and feed analysis followed by his positions as Vice President Clinical Diagnostics. In this function, as an Authorised Representative he was also a member of the senior management team.



The Supervisory Board of CO.DON advises the Executive Board regularly on the management of the company. It verifies that company management is lawful, fit for purpose and cost-effective and in carrying out its tasks works closely with the other company decision-making bodies for the good of the company. The CO.DON Supervisory Board is made up of representatives of our shareholders and of independent business and financial experts. Its balanced membership ensures that the board is diverse and competent. The Supervisory Board consists of six members.

Thommy Stählin


Mr Stählin obtained his Federal Banking Diploma (the highest banking qualification in Switzerland) in 1985 and then worked as an authorised signatory of Schweizerischer Bankverein in Zurich. In 1988 he moved for two years to American Express Bank AG (Switzerland), where he held the position of Vice-President and Head of Commercial Banking. In 1990 Mr Stählin became managing director of Manpower AG, Zurich, before joining INSPI CONSULTING AG, Zurich (Denner Group) in 1992 as managing director.

Thommy Stählin founded stählin consulting, a business consultancy, in 1999. He applies his extensive experience and wide-ranging commercial expertise to advise small and medium-sized companies, especially in strategic planning. In addition, he holds numerous directorships, also of publicly listed companies.

Thommy Stählin was elected to the Supervisory Board of CO.DON AG for the first time in 2005.

Prof. Dr. Barbara Sickmüller

Deputy Chair

Prof. Barbara Sickmüller is a pharmacist – she studied and completed her PhD at Philipps University in Marburg. Since 1977 she has held various roles in the federal German pharmaceutical association (BPI). She was appointed Deputy Managing Director of the BPI in 2000.

She has been a member of various expert committees and commissions convened by the German Federal Health Ministry, including the Expert Committee for Prescription Medicines, the Commission for Medicines for Children and Adolescents (KAKJ), a member of the Board of Trustees of the Institute for Quality and Cost-effectiveness in Healthcare (IQWiG) and a guest member of the Board of Trustees of the German Agency for Health Technology Assessment (HTA) within the DIMDI.

Professor Sickmüller was made an honorary professor of Philipps University Marburg in 2000. Prof. Sickmüller retired in March 2012 and since then has worked with the BPI as a Senior Scientific Advisor. On 1 July 2014 she became President of the German Society for Regulatory Affairs (DGRA) and on 1 October 2014 a member of the Advisory Board of Technical University Mittelhessen in Gießen.

Prof. Barbara Sickmüller was elected to the Supervisory Board of CO.DON AG for the first time in 2010.

Univ.-Prof. Dr.-Ing. habil. Prof. E.h. mult. Dr. h.c. mult. Hans-Jörg Bullinger

Prof. Dr. Hans-Jörg Bullinger was President of the Fraunhofer Society in Munich from 2002 to 2012 and Senator of the Fraunhofer Society from 2013-2018. Prof. Bullinger studied engineering, completing his PhD and habilitation degree at Stuttgart University before holding leading posts in applied research and teaching at a young age. He founded the Fraunhofer Institute for Ergonomics and Organisation (IAO) and the Institute for Ergonomics and Technology Management (IAT) at Stuttgart University.

Prof. Bullinger is a Fellow of the Royal Academy of Engineering (UK) and was a member of several High Level Groups convened by the European Commission (2012-2015). Along with Dr. Arend Oetker, Prof. Bullinger was Chair of the Business-Science research partnership set up by the Federal Ministry for Education and Research (2006-2012), which was the federal government’s main innovation policy advisory board, contributing to the development of Germany’s high-tech strategy 2020.

He has received many awards and several honorary doctorates and professorships. In 2009 Hans-Jörg Bullinger was voted Manager of the Year and in 2013 inducted into the Hall of Fame of German Research.

Prof. Dr. Hans-Jörg Bullinger was elected to the Supervisory Board of CO.DON AG for the first time in 2019.